| RS1830715947 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS1830717066 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS1830722833 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1830724241 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1830731482 |
RELN
|
Health Risk |
Likely pathogenic |
— |
| RS1830740171 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1830753335 |
ABCA1
|
Health Risk |
Pathogenic |
— |
| RS183077332 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183077397 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Inborn genetic diseases |
| RS183077797 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary von Willebrand disease, Hereditary von Willebrand disease |
| RS1830815799 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS183087139 |
PGK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Inborn genetic diseases |
| RS183087425 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS183088493 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS183092299 |
CDKL5;RS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile retinoschisis, RS1-related disorder |
| RS1830934754 |
GABBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Inborn genetic diseases |
| RS1830947762 |
ABL1
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS1830947813 |
ABL1
|
Health Risk |
Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS1830948350 |
ABL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS1830954329 |
COL27A1
|
Health Risk |
Pathogenic |
Steel syndrome, Steel syndrome |
| RS1830959398 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS183097128 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NEFH-related disorder |
| RS183101063 |
OCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS1831038541 |
NSMF
|
Health Risk |
Pathogenic |
Pituitary stalk interruption syndrome, Pituitary stalk interruption syndrome |
| RS1831052831 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS183105855 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, GALC-related disorder |
| RS1831067002 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1831076152 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1831079386 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS1831081460 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1831082309 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1831082433 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1831097846 |
ABL1
|
Health Risk |
Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS1831099962 |
ABL1
|
Health Risk |
Pathogenic/Likely pathogenic |
ABL1-related disorder, ABL1-related disorder |
| RS1831100789 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS1831100970 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS1831103567 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1831124823 |
MAN1B1
|
Health Risk |
Likely pathogenic |
— |
| RS183114391 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS183114696 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1831149748 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1831150965 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1831159822 |
MAN1B1
|
Health Risk |
Likely pathogenic |
— |
| RS1831161564 |
TJP2
|
Health Risk |
Likely pathogenic |
— |
| RS1831165670 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS183117027 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1831171802 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1831172189 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1831176210 |
FANCC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1831179586 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS183118123 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS1831182314 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group C, Fanconi anemia |
| RS1831182685 |
FRRS1L
|
Health Risk |
Likely pathogenic |
— |
| RS1831183107 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS1831184766 |
FRRS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS1831189846 |
ALDOB
|
Health Risk |
Pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1831190354 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1831191030 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1831192129 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS183119644 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1831209087 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS183126539 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF469-related disorder, Cardiovascular phenotype |
| RS1831271059 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS183130 |
CETP
|
Health Risk |
association |
High density lipoprotein cholesterol level quantitative trait locus 10, High density lipoprotein cholesterol level quantitative trait locus 10 |
| RS183130427 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS183130583 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS1831307625 |
FRRS1L
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS183131461 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1831316527 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183136193 |
TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Sarcotubular myopathy |
| RS1831388695 |
ABL1
|
Health Risk |
Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS183141256 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital Muscular Dystrophy, alpha-dystroglycan related |
| RS183141566 |
RIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
RIN2-related disorder, RIN2-related disorder |
| RS183142477 |
PRDM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1831432715 |
ABL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS1831432776 |
ABL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Microcephaly |
| RS1831433011 |
ABL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS1831437006 |
WDR91
|
Health Risk |
Likely pathogenic |
— |
| RS183144150 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS1831457676 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS183149417 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1831540545 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1831540987 |
RELN
|
Health Risk |
Likely pathogenic |
Familial temporal lobe epilepsy 7, Familial temporal lobe epilepsy 7 |
| RS1831543477 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS183154447 |
AFG2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1831596883 |
LHX3
|
Health Risk |
Likely pathogenic |
— |
| RS183159689 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, OTOGL-related disorder |
| RS183161718 |
ACADS
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS1831666357 |
KCNT1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS1831669014 |
KCNT1
|
Health Risk |
Pathogenic |
— |
| RS183168007 |
LCT
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactase deficiency, LCT-related disorder |
| RS1831680321 |
LHX3
|
Health Risk |
Likely pathogenic |
— |
| RS1831682062 |
LHX3
|
Health Risk |
Pathogenic |
— |
| RS1831682631 |
LHX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Non-acquired combined pituitary hormone deficiency with spine abnormalities |
| RS183168709 |
KIAA0586
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS183171123 |
ACSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1831725857 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS1831726447 |
RELN
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS1831789627 |
KCNT1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS1831817207 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Infantile nephronophthisis |